Christophe Lancon, MD, PhD
- 5Articles
- 24.6KReads
- 2012–2019Active
- 60Collaborators
- 201Citations
About
Christophe Lancon, MD, PhD, has contributed to research on schizophrenia and schizoaffective disorders, treatment-resistant depression, and related neurological conditions. His publications address metabolic syndrome prevalence and risk factors in psychiatric populations, extrapyramidal side effects of antipsychotics, and neuroimaging findings in rare diseases linked to psychosis. Lancon's work spans clinical studies on depression, schizophrenia, and neurological disorders such as Fahr disease and Leber's hereditary optic neuropathy.
Publications
Metabolic Syndrome in Treatment-Resistant Depression
October 15, 2019
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
